HPV-transformed cells exhibit altered HMGB1-TLR4/MyD88-SARM1 signaling axis
Open Access
- 22 February 2018
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-11
Abstract
Cervical cancer is one of the leading causes of cancer death in women worldwide. Persistent infection with high-risk human papillomavirus (HPV) types is the main risk factor for the development of cervical cancer precursor lesions. HPV persistence and tumor development is usually characterized by innate immune system evasion. Alterations in Toll-like receptors (TLR) expression and activation may be important for the control of HPV infections and could play a role in the progression of lesions and tumors. In the present study, we analyzed the mRNA expression of 84 genes involved in TLR signaling pathways. We observed that 80% of the differentially expressed genes were downregulated in cervical cancer cell lines relative to normal keratinocytes. Major alterations were detected in genes coding for several proteins of the TLR signaling axis, including TLR adaptor molecules and genes associated with MAPK pathway, NFκB activation and antiviral immune response. In particular, we observed major alterations in the HMGB1-TLR4 signaling axis. Functional analysis also showed that HMGB1 expression is important for the proliferative and tumorigenic potential of cervical cancer cell lines. Taken together, these data indicate that alterations in TLR signaling pathways may play a role in the oncogenic potential of cells expressing HPV oncogenes.Keywords
This publication has 43 references indexed in Scilit:
- HMGB1 in health and diseaseMolecular Aspects of Medicine, 2014
- IRAK signalling in cancerBritish Journal of Cancer, 2014
- Mitochondrial Dysfunction Induces Sarm1-Dependent Cell Death in Sensory NeuronsThe Journal of Neuroscience, 2014
- Beyond MyD88 and TRIF Pathways in Toll-Like Receptor SignalingFrontiers in Immunology, 2014
- The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoterJournal of Experimental Medicine, 2013
- HMGB1 was a pivotal synergistic effecor for CpG oligonucleotide to enhance the progression of human lung cancer cellsCancer Biology & Therapy, 2012
- Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancerTrends in Immunology, 2010
- TLR4‐mediated skin carcinogenesis is dependent on immune and radioresistant cellsThe EMBO Journal, 2010
- Immune evasion in human papillomavirus-associated cervical cancerNature Reviews Cancer, 2002
- The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.Proceedings of the National Academy of Sciences, 1991